361 related articles for article (PubMed ID: 18065807)
41. [Nephropathy in human immunodeficiency virus infection].
Esforzado N; Feliz T; Almirall J; Torras A; Miró JM; Gatell JM; Revert L
Med Clin (Barc); 1992 May; 98(20):764-7. PubMed ID: 1635392
[TBL] [Abstract][Full Text] [Related]
42. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
[TBL] [Abstract][Full Text] [Related]
43. Prevalence and risk of hypertension in renal disease--data from the Czech Registry of Renal Biopsies.
Jancova E; Vankova Z; Honsova E; Lanska V; Rysava R; Merta M; Rychlik I; Viklicky O; Zadrazil J; Hertlova M; Sobotova D; Cifkova R; Tesar V;
Kidney Blood Press Res; 2008; 31(2):135-42. PubMed ID: 18418004
[TBL] [Abstract][Full Text] [Related]
44. Microvascular and macrovascular complications in diabetic nephropathy patients referred to nephrology clinic.
Al-Wakeel JS; Hammad D; Al Suwaida A; Mitwalli AH; Memon NA; Sulimani F
Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):77-85. PubMed ID: 19112222
[TBL] [Abstract][Full Text] [Related]
45. Concomitant macro and microvascular complications in diabetic nephropathy.
Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
[TBL] [Abstract][Full Text] [Related]
46. Chronic kidney disease and global cardiovascular risk in essential hypertension.
Segura J; Campo C; Ruilope LM
Minerva Med; 2004 Oct; 95(5):375-83. PubMed ID: 15467513
[TBL] [Abstract][Full Text] [Related]
47. Renal disease in an antiretroviral-naïve HIV-infected outpatient population in Western Kenya.
Wools-Kaloustian K; Gupta SK; Muloma E; Owino-Ong'or W; Sidle J; Aubrey RW; Shen J; Kipruto K; Zwickl BE; Goldman M
Nephrol Dial Transplant; 2007 Aug; 22(8):2208-12. PubMed ID: 17652119
[TBL] [Abstract][Full Text] [Related]
48. Diabetic retinopathy is a poor predictor of type of nephropathy in proteinuric type 2 diabetic patients.
Prakash J; Lodha M; Singh SK; Vohra R; Raja R; Usha
J Assoc Physicians India; 2007 Jun; 55():412-6. PubMed ID: 17879494
[TBL] [Abstract][Full Text] [Related]
49. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.
Munkhaugen J; Lydersen S; Widerøe TE; Hallan S
Am J Kidney Dis; 2009 Oct; 54(4):638-46. PubMed ID: 19515474
[TBL] [Abstract][Full Text] [Related]
50. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
Hofstra JM; Deegens JK; Willems HL; Wetzels JF
Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774
[TBL] [Abstract][Full Text] [Related]
51. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
[TBL] [Abstract][Full Text] [Related]
52. Renal disease in the acquired immunodeficiency syndrome in north central Nigeria.
Agaba EI; Agaba PA; Sirisena ND; Anteyi EA; Idoko JA
Niger J Med; 2003; 12(3):120-5. PubMed ID: 14737980
[TBL] [Abstract][Full Text] [Related]
53. Assessment of proteinuria as a marker of nephropathy in type 2 diabetes mellitus.
Aryal M; Jha B
Nepal Med Coll J; 2006 Dec; 8(4):250-3. PubMed ID: 17357643
[TBL] [Abstract][Full Text] [Related]
54. Collapsing glomerulopathy--a new pattern of renal injury.
Laurinavicius A; Rennke HG
Semin Diagn Pathol; 2002 Aug; 19(3):106-15. PubMed ID: 12180632
[TBL] [Abstract][Full Text] [Related]
55. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
Rutkowski M; Mann W; Derose S; Selevan D; Pascual N; Diesto J; Crooks P
Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
[TBL] [Abstract][Full Text] [Related]
56. Failure of predicted creatinine clearance equations in HIV-seropositive patients.
Smith BL; Sarnoski TP; Dennis S; Luke DR
Int J Clin Pharmacol Ther Toxicol; 1992 Oct; 30(10):394-9. PubMed ID: 1446956
[TBL] [Abstract][Full Text] [Related]
57. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study.
Sturm G; Kollerits B; Neyer U; Ritz E; Kronenberg F;
Exp Gerontol; 2008 Apr; 43(4):347-52. PubMed ID: 18294794
[TBL] [Abstract][Full Text] [Related]
58. The epidemiology of adult chronic kidney disease in a population-based study in Iran: prevalence and associated risk factors.
Safarinejad MR
J Nephrol; 2009; 22(1):99-108. PubMed ID: 19229824
[TBL] [Abstract][Full Text] [Related]
59. Prevalence of active pulmonary tuberculosis in human immunodeficiency virus seropositive adult patients in University College Hospital, Ibadan, Nigeria.
Awoyemi OB; Ige OM; Onadeko BO
Afr J Med Med Sci; 2002 Dec; 31(4):329-32. PubMed ID: 15027773
[TBL] [Abstract][Full Text] [Related]
60. Abnormal urinary protein excretion in HIV-infected patients.
Kimmel PL; Umana WO; Bosch JP
Clin Nephrol; 1993 Jan; 39(1):17-21. PubMed ID: 8428402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
